AYTU BIOPHARMA CEO Joshua Disbrow's 2020 pay jumps 52% to $1.6M
AYTU BIOPHARMA reports 2020 executive compensation
By ExecPay News
Published: April 7, 2022
AYTU BIOPHARMA reported fiscal year 2020 executive compensation information on April 7, 2022.
In 2020, three executives at AYTU BIOPHARMA received on average a compensation package of $1.2M, a 53% increase compared to previous year.
Average pay of disclosed executives at AYTU BIOPHARMA
Joshua R. Disbrow, Chief Executive Officer, received $1.6M in total, which increased by 52% compared to 2019. 41% of Disbrow's compensation, or $653K, was in stock awards. Disbrow also received $185K in bonus, $140K in option awards, as well as $608K in salary.
David A. Green, Chief Financial Officer, received a compensation package of $1.1M, which increased by 53% compared to previous year. 38% of the compensation package, or $400K, was in salary.
since December David A. Green, Chief Financial Officer, earned $1.1M in 2020, a 53% increase compared to previous year.
AYTU BIOPHARMA's fiscal year ends on June 30.
Related executives
You may also like
Source: SEC filing on April 7, 2022.